Saturday, 17 October 2026European Markets

ERAMET Stock Went Up By Over 20% In The Last 10 Sessions

Loading stream...

(vianews) - shares of eramet (cac 40: era.pa) rose by a staggering 20.58% in 10 sessions from 89.65 € to 108.10 € at 01:56 est on friday, following the last session's downward trend. cac 40 is rising 0.96% to 7,188.36 €, after three consecutive sessions in a row of losses.

about eramet

eramet s.a. operates as a mining and metallurgical company worldwide. the company extracts and processes manganese ore, nickel ore, and mineral sands. it also produces ferronickel, high purity nickel metal, nickel salts, nickel and cobalt chlorides, nickel carbonate, nickel ferroalloys, and other metallic salts used in stainless steel, catalysis and pigments, and alloy steel and casting; manganese alloys, such as high-carbon ferromanganese, silicomanganese, low and medium-carbon ferromanganese, and low-carbon silicomanganese for use in batteries, fertilizers, pigments, different reagents, construction, and automotive industries; and mineral sands, such as titanium dioxide, high-purity pig iron, zircon, and ilmenite used in ceramics and pigments. in addition, it operates moanda mine in gabon; nickel mines in new caledonia and indonesia; and mineral sand mine in senegal and argentina. eramet s.a. was incorporated in 1880 and is headquartered in paris, france.

earnings per share

as for profitability, eramet has a trailing twelve months eps of -25.47 €.

volume

today's last reported volume for eramet is 53187 which is 22.22% below its average volume of 68389.

volatility

eramet's last week, last month's, and last quarter's current intraday variation average was 0.25%, 1.03%, and 2.26%.

eramet's highest amplitude of average volatility was 1.19% (last week), 2.08% (last month), and 2.26% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, eramet's stock is considered to be oversold (<=20).

more news about eramet (era.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com